Turnstone Estates has submitted a revised planning application for unit 1 at Pampisford Park, the south Cambridge business and science park development.
Planning application submitted for Pampisford Park
Detailed planning consent already exists for a 14,725 sq ft (1,368 sqm) gross internal area self-contained unit. The revised plans are for a 17,400 sq ft (1,617 sqm) two-storey laboratory and/or office building. Pending planning consent, Turnstone will make a speculative start in early 2006.
Chris Goldsmith, managing director of Turnstone Estates, comments: 'The take-up of units 2 and 3 has shown the success of Pampisford Park as a high-technology and biotechnology cluster, and has given us the confidence to commence speculative development.'
Other tenants at the 3.53 acre site are Sareum Limited, the biotech company occupying unit 2 and Xention Discovery, a drug discovery company, occupying unit 3.
The letting agents are Januarys and Jeffersons.
Established in 1989, Turnstone is one of the most active and dynamic property companies in the south east of England.